Zimmer Returns To Higher Pricing After HCA Misses Purchasing Targets
This article was originally published in The Gray Sheet
Executive Summary
Zimmer is returning to pre-contract pricing levels after the hospital group HCA failed to meet purchasing requirements under a vendor contract
You may also be interested in...
Ortho Firms And Docs Claim That Gainsharing Reality Is Not Meeting Its Hype
Zimmer and Stryker say they will not renew their gainsharing contracts with HCA because they have not achieved the sales volume gains they anticipated
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.